Skip to main content
. 2023 Dec 11;14:1304970. doi: 10.3389/fendo.2023.1304970

Table 2.

Comparison of the subgroups of adolescents with obesity with BMI-SDS reduction vs. increase/no change of the BMI-SDS during the follow up.

Parameter BMI-SDS increase/no change BMI-SDS decrease p
Baseline data
Age (years) 16.61 ± 0.89 (71) 16.57 ± 0.97 (73) 0.786
Sex (% of girls) 50.7 (73) 43.8 (71) 0.504
Weight (kg) 102 ± 25.25 (71) 103.61 ± 17.56 (73) 0.660
Height (cm) 172.68 ± 9.42 (71) 173.58 ± 9.62 (73) 0.570
Height SDS 0.07 ± 1.18 (71) 0.06 ± 0.97 (73) 0.955
BMI (kg/m2) 34.08 ± 7.43 (71) 34.29 ± 4.74 (73) 0.841
BMI SDS 4.91 ± 2.76 (71) 4.97 ± 1.77 (73) 0.890
TSH (mU/l)* 2.73; 1.9-3.9 (71) 2.23; 1.59-3.19 (71) 0.005
FT4 (pmol/l) 15.49 ± 2.74 (71) 14.66 ± 2.2 (73) 0.048
FT3 (pmol/l) 6.09 ± 1.22 (27) 6.24 ± 1.04 (41) 0.607
Fasting serum glucose (mmol/l)* 4.8; 4.5-5.2 (64) 4.8; 4.5-5.1 (64) 0.907
Urea (mmol/l) 3.8 ± 1.03 (59) 3.91 ± 0.81 (52) 0.541
Creatinine (mmol/l) 62.55 ± 10.52 (65) 64.6 ± 11.04 (72) 0.271
Uric acid (μmol/l) 368.8 ± 87.93 (64) 392.29 ± 89.28 (70) 0.128
Total serum proteins (g/l) 72.34 ± 4.22 (25) 73.74 ± 5.81 (18) 0.364
AST (μkat/l)* 0.37; 0.32-0.53 (64) 0.4; 0.34-0.5 (68) 0.651
ALT (μkat/l)* 0.43; 0.26-0.62 (66) 0.46; 0.35-0.73 (69) 0.316
GGT (μkat/l)* 0.305; 0.2-0.46 (26) 0.37; 0.28-0.49 (30) 0.537
ALP (μkat/l)* 1.5; 1.27-2 (40) 1.63; 1.33-1.93 (40) 0.557
Total-cholesterol (mmol/l) 4.25 ± 1.09 (62) 4.07 ± 0.72 (66) 0.300
HDL-cholesterol (mmol/l) 1.14 ± 0.23 (55) 1.11 ± 0.27 (64) 0.477
LDL-cholesterol (mmol/l) 2.78 ± 0.82 (54) 2.6 ± 0.64 (64) 0.192
Triglycerides (mmol/l) 1.29 ± 0.54 (62) 1.33 ± 0.63 (66) 0.698
Insulin (mU/l) 30.67 ± 25.08 (33) 30.58 ± 25.9 (48) 0.987
High Sugar score 5.57 ± 1.37 (6) 5.25 ± 1.01 (6) 0.647
High Complex Carbohydrate score 6 ± 0.97 (6) 5.35 ± 0.9 (6) 0.259
High Protein score 5.6 ± 0.91 (6) 5.23 ± 2.17 (6) 0.710
High Fat score 5.5 ± 0.86 (6) 5.41 ± 1.23 (6) 0.882
Low Fiber score 5.9 ± 0.9 (5) 5.39 ± 2.05 (4) 0.631
Score for foods cotaining ≥1.5g of Saturated FA per 100g 5.55 ± 0.81 (5) 5.35 ± 1.58 (4) 0.805
Score for foods cotaining ≥1.5g of Polysaturated FA per 100g 5.6 ± 0.81 (5) 5.47 ± 1.48 (4) 0.869
Score for foods cotaining ≥1.5g of Monosaturated FA per 100g 5.68 ± 0.83 (5) 5.35 ± 1.41 (4) 0.674
Follow-up data
BMI (kg/m2) 35.59 ± 7.74 (71) 32.63 ± 4.81 (73) 0.007
BMI SDS 5.46 ± 2.87 (71) 4.33 ± 1.8 (73) 0.006
Duration of the follow-up (years) 5.52 ± 2.04 (71) 5.16 ± 1.80 (73) 0.271
BMI change 1.51 ± 1.5 (71) -1.66 ± 1.63 (73) <0.001
BMI-SDS change 0.55 ± 0.56 (71) -0.63 ± 0.6 (73) <0.001
BMI-SDS change per year 1.27 ± 1.24 (71) -1.59 ± 1.59 (73) <0.001

*Non-normally distributed data (TSH, fasting serum glucose, AST, ALT, GGT and ALP) are presented as the median and interquartile range, and were log-transformed prior t-test. TSH, Thyroid-stimulating hormone; FT4, free thyroxine; FT3, free triiodothyronine; BMI, body mass index; SDS, standard deviation score; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma-glutamyl transferase; ALP, alkaline phosphatase; FA, fatty acids. Value in parentheses (number of participants). P value was calculated in t-test for the difference between populations of adolescents with obesity and 1. children with obesity and 2. non-obese adolescents. All significant values (p<0.05) are in bold.